[go: up one dir, main page]

WO2021236013A1 - Appareil de traitement et procédé de déploiement d'un appareil de traitement - Google Patents

Appareil de traitement et procédé de déploiement d'un appareil de traitement Download PDF

Info

Publication number
WO2021236013A1
WO2021236013A1 PCT/SG2021/050274 SG2021050274W WO2021236013A1 WO 2021236013 A1 WO2021236013 A1 WO 2021236013A1 SG 2021050274 W SG2021050274 W SG 2021050274W WO 2021236013 A1 WO2021236013 A1 WO 2021236013A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment apparatus
confined space
panels
fan
air
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SG2021/050274
Other languages
English (en)
Inventor
Deborah KHOO
Ngeow Khing CHIA
Wai Tung CHOW
Sui Ming Raymond HON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
National University Hospital Singapore Pte Ltd
Original Assignee
National University of Singapore
National University Hospital Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore, National University Hospital Singapore Pte Ltd filed Critical National University of Singapore
Priority to CN202180044051.2A priority Critical patent/CN116033880A/zh
Publication of WO2021236013A1 publication Critical patent/WO2021236013A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G10/00—Treatment rooms or enclosures for medical purposes
    • A61G10/005—Isolators, i.e. enclosures generally comprising flexible walls for maintaining a germ-free environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/40—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G10/00—Treatment rooms or enclosures for medical purposes
    • A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
    • A61L9/18—Radiation
    • A61L9/20—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/40—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
    • A61B2090/401—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment using air flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10—Apparatus features
    • A61L2209/14—Filtering means

Definitions

  • the present disclosure relates broadly, but not exclusively, to a treatment apparatus serving as a protective equipment, and to a method of deploying the treatment apparatus.
  • Droplets generated by patients may carry pathogens and/or infectious particles which are harmful for healthcare workers providing treatments to these patients. These droplets may be generated by coughing, sneezing, and speaking of patients with contagious diseases, or may be generated from aerosols produced as a result of medical procedures, for example “Aerosol Generating Procedures” (AGPs), performed on these patients.
  • AGPs include a wide range of commonly performed procedures such as intubation, extubation, endoscopy, cardiopulmonary resuscitation (CPR), laparoscopy and bronchoscopy, which are often unavoidable.
  • CPR cardiopulmonary resuscitation
  • These harmful droplets produced by the patients have the potential to hang around in the air for some time, or may stay on surfaces for prolonged periods. Healthcare workers who work in close proximity to these patients are therefore at high risk of being exposed to such droplets and/or aerosols generated by these patients.
  • aspects of the present application relate to a treatment apparatus and a method of deploying a treatment apparatus.
  • a treatment apparatus comprising: a plurality of panels assembled to form a chamber to provide a confined space for at least partially enclosing a patient therein; a fan adapted to connect to an air filter; and an exhaust opening provided in one of the plurality of panels, the exhaust opening being adapted to connect to the fan, wherein the fan is adapted to generate an air flow from the confined space, via the air filter, to an external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • the treatment apparatus By having the plurality of panels assembled to form a chamber to provide a confined space that at least partially enclosing a patient therein, droplets and/or aerosol produced by a patient can be contained to limit exposure of these droplets and/or aerosol to the external environment.
  • the treatment apparatus therefore creates a physical barrier to protect healthcare providers providing aids to the patient from potential pathogens, germs and/or virus produced from the patient.
  • the exhaust opening provided is adapted to connect to the fan, where the fan is adapted to generate an air flow from the confined space to the external environment. In this way, the droplets and/or aerosol produced by the patient within the confined space can be filtered out before the air from the confined space is exhausted to the external environment, thereby minimising contamination of the external environment. Further, by generating this air flow, fresh air from the external environment can be drafted into the confined space to ventilate the confined space (note that the confined space is not air tight). This provides an oxygen-enhanced environment for the patient during performance
  • the fan may comprise an ultra violet C (UV-C) light column adapted to emit UV-C light to treat the air from the confined space.
  • UV-C ultra violet C
  • the UV-C light is effective in removing infectious particles or micro-organisms, thereby ensuring that the air exhausted from the confined space is pathogens, germs or virus free.
  • the treatment apparatus may comprise one or more ultra violet C (UV-C) light columns arranged within the confined space adapted to emit UV-C light towards at least a surface of one of the plurality of panels.
  • UV-C ultra violet C
  • the UV-C is effective in removing infectious particles or micro organisms and thus keeping the patient safe within the confined space of the chamber.
  • the UV-C light may have a wavelength between 200 nm and 300 nm.
  • the UV-C light of this wavelength range is strongly absorbed by nucleic acids, thereby aiding disinfection of infectious particles or microorganisms within the chamber, or in the exhausted air from the confined space of the chamber.
  • the plurality of panels may comprise wall panels and a top panel securable to the wall panels when deployed, the top panel being arranged on top of the wall panels. Securing the wall panels to the top panel provide a rigid and sturdy structure of the chamber, and improve a stability of the treatment apparatus, particularly during the performance of a procedure on the patient.
  • the treatment apparatus may comprise through holes in the wall panels, and the through holes being adapted to provide access to the confined space.
  • the through holes provide access to the confined space so that health workers may perform a procedure on the patient.
  • the treatment apparatus may comprise snap-in flanges each provided to engage a perimeter of each of the through holes for securing to each of the through holes at least one of: a cover of the through hole and a user protection sleeve.
  • the snap-in-flanges allow for customizability of an arm port covering (sleeves or diaphragm). Further, given the snap-in features, it means that the cover of the through hole or the user protection sleeve can be replaced easily. This allows for easy cleaning of the through hole covers or user protection sleeves if necessary.
  • the snap-in flanges may be made of polyoxymethylene.
  • Adjacent panels of the wall panels may be connected to each other via at least one living hinge.
  • the top panel may be connected to a top edge of one of the wall panels via at least one living hinge.
  • the at least one living hinge may be made of carbon reinforced nylon.
  • the top panel and the wall panels may be made of polycarbonate.
  • the wall panels may comprise a front panel and two side panels, and wherein the at least one through hole may comprise two through holes provided in the front panel.
  • the treatment apparatus may comprise a covering connected to the top panel, the covering may be adapted to cover at least an opposite side of the chamber to the front panel. The covering acts as a protective covering to reduce air from the confined space of the chamber from leaking out to the external environment and to prevent any droplets produced in a procedure to be exposed to the external environment.
  • the exhaust opening may be provided in the top panel.
  • the exhaust opening may be provided near or at a bottom of one of the wall panels.
  • the air filter may comprise a high efficiency particulate air (HEPA) filter.
  • HEPA high efficiency particulate air
  • the air filter may comprise an ultra low penetration air (ULPA) filter.
  • ULPA ultra low penetration air
  • the treatment apparatus may comprise fastening means connected to a bottom side of one of the wall panels for securing a position of the treatment apparatus.
  • the fastening means allow the treatment apparatus to be secured to a structure on which the patent is placed (e.g. a bed frame, an operating table or a stretcher etc.) to provide stability of the treatment apparatus and to ensure that the treatment apparatus is not displaced during performance of a procedure on the patient.
  • the fan may include a variable speed centrifugal fan.
  • kit of parts arranged to be assembled for forming any one of the preceding treatment apparatus.
  • the kit of parts may include the plurality of panels arranged to form the chamber, wherein the plurality of panels are substantially flat and are arranged to be flat-packed together. The ability for the plurality of panels to be flat-packed improves a portability of the treatment apparatus, and enables the panels to be easily transported, stored or to be disinfected.
  • a method of deploying a treatment apparatus comprising a plurality of panels assembled to form a chamber to provide a confined space for at least partially enclosing a patient therein, a fan adapted to connect to an air filter, and an exhaust opening provided in one of the plurality of panels adapted to connect to the fan, the fan being adapted to generate an air flow from the confined space, via the air filter, to an external environment for drafting air from the external environment into the confined space to ventilate the confined space, the method comprising: assembling the plurality of panels to form the chamber; connecting the fan to the exhaust opening; and using the fan for generating the air flow from the confined space, via the air filter, to the external environment to draft the air from the external environment into the confined space to ventilate the confined space.
  • the method may comprise decontaminating interior surfaces of the chamber before and after each use of the treatment apparatus. This improves a hygiene of the treatment apparatus, particularly, if the treatment apparatus is to be reused on a next patient.
  • the method may comprise using the fan to provide at least 15 or more air exchanges between the confined space and the external environment.
  • a treatment apparatus for at least partially enclosing a patient therein during treatment.
  • the treatment apparatus comprising: flat- packable wall panels deployable to form a chamber for providing a confined space for at least partially enclosing the patient therein; a top panel securable to the wall panels when deployed; an exhaust opening provided in one of: the top panel and the wall panels for allowing air from the confined space to flow to an external environment; and through holes provided in the wall panels adapted to provide access to the confined space.
  • the treatment apparatus may comprise snap-in flanges each provided to engage a perimeter of each of the through holes for securing to each of the through holes at least one of: a cover of the through hole and a user protection sleeve.
  • the treatment apparatus may comprise a fan adapted to connect to an air filter, wherein the exhaust opening may be adapted to connect to the fan, and the fan may be adapted to generate an air flow from the confined space, via the air filter, to the external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • the fan may include a portable vacuum pump system for field deployment.
  • a treatment apparatus comprising: a plurality of panels assembled to form a chamber to provide a confined space for at least partially enclosing a patient therein; a vacuum pump adapted to connect to an air filter; and an exhaust opening provided in one of the plurality of panels, the exhaust opening being adapted to connect to the vacuum pump, wherein the vacuum pump is adapted to generate an air flow from the confined space, via the air filter, to an external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • Embodiments therefore provide a treatment apparatus that creates a physical barrier to protect healthcare providers providing aids to the patient from potential pathogens, germs and/or virus produced from the patient.
  • an exhaust opening is provided in the treatment apparatus.
  • the exhaust opening is adapted to connect to a fan in connection to an air filter, and the fan is adapted to generate an air flow from the confined space to the external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • the droplets and/or aerosol produced by the patient within the confined space can be filtered out before the air from the confined space is exhausted to the external environment, thereby minimising contamination of the external environment.
  • Figure 1 shows a treatment apparatus in a deployed state according to an embodiment, the treatment apparatus as shown includes a plurality of panels assembled to form a chamber and a fan or a vacuum pump connected to an exhaust opening of the treatment apparatus;
  • Figure 2 shows the plurality of panels of the treatment apparatus of Figure 1 in a storage or flat-packed state
  • Figure 3 shows the treatment apparatus of Figure 1 together with removable snap-in flanges which can be fitted onto through holes of the plurality of panels according to an embodiment
  • Figure 4 shows an integrated locking feature of the treatment apparatus according to an embodiment, where during deployment, the plurality of panels are unfolded to form the chamber with a top panel of the plurality of panels being connected to side panels of the plurality of panels using a peg-in-hole type of locking feature;
  • FIG 5 shows the fan unit or the vacuum pump being connected to the exhaust opening of the treatment apparatus of Figure 1 according to an embodiment
  • Figure 6 shows various dimensions of the treatment apparatus of Figure 1 according to an embodiment, where the dimensions as shown are measured in millimetres.
  • Exemplary embodiments relate to a treatment apparatus and a method for deploying a treatment apparatus.
  • a treatment apparatus serving as a protective equipment for healthcare workers when they treat patients with contagious diseases.
  • the treatment apparatus comprises a plurality of panels assembled to form a chamber to provide a confined space for at least partially enclosing a patient therein.
  • An exhaust opening is provided in one of the plurality of panels, and is adapted to connect to a fan.
  • the fan is adapted to connect to an air filter, and is configured to generate an air flow from the confined space, via the air filter, to an external environment for drafting air from the external environment into the confined space to ventilate the confined space. This air flow created by the fan drafts air into the confined space based on the Bernoulli's principle.
  • the chamber is not air-tight and therefore air from the external environment can enter the chamber (e.g. from through holes formed in the panels and/or gaps in the chamber) to create an oxygen-enhanced environment for the patient during performance of the procedure.
  • the physical principle of the air flow is such that a partial vacuum needs not be created within the confined space to draft air from the external environment into the confined space. Rather, the generated air flow from the confined space, via the air filter, to the external environment drafts air from the external environment to the confined space due to the principle of mass continuity (or conservation of mass).
  • a circulation of air is therefore generated by the treatment apparatus of the present invention, where air from the confined space is being purified by the air filter and exhausted out to the external environment, while fresh air from the external environment enters into the confined space of the chamber to provide an oxygen-enhanced environment for the patient.
  • Figure 1 shows a treatment apparatus 100 in a deployed state according to an embodiment.
  • the treatment apparatus 100 includes a plurality of panels assembled to form a chamber 101.
  • the plurality of panels includes three wall panels 102, 104 and 106 forming the walls of the chamber 101 , and a top panel 108 connected to top edges of the three wall panels 102, 104, 106.
  • a first and second through holes 102a, 102b are provided in a front panel 102 of the wall panels, while a third through hole 104a is provided in a side panel 104 of the wall panels.
  • These through holes (102a, 102b, 104a) are adapted to provide accessibility to the confined space within the chamber 101.
  • an exhaust opening 110 is also shown in Figure 1 adapted to provide accessibility to the confined space within the chamber 101.
  • the exhaust opening 110 is a through hole through the top panel 108 and provides a passage for air to flow from the confined space and the external environment (i.e. environment outside of the confined space of the chamber 101).
  • the exhaust opening 110 provides a connection to a fan (or a vacuum pump) 112.
  • the exhaust opening 110 may be adapted to connect to the fan 112 using a port. It should be appreciated that the connection of the exhaust opening 110 to the fan 112 should be air-tight to ensure good suction strength of the fan 112 is maintained.
  • term “fan” should be understood as any form of mechanism which allows air to be drawn out of the confined space to the external environment.
  • the fan includes a variable speed centrifugal fan.
  • the fan may therefore be adapted to transport a gas load from the confined space via the exhaust opening to the external environment through an outlet of the fan.
  • the fan 112 is connected to an air filter (not shown) for filtering the air exhausted from the confined space to the external environment.
  • the air filter may be connected between the exhaust opening and the fan, or at the outlet of the fan.
  • This laminar air flow allows for pathogen-carrying droplet and aerosol laden air within the chamber 101 to be filtered out.
  • This movement of air from the confined space of the chamber 101 to the external environment is advantageous as this reduces the amount of unfiltered air leak occurring from the non-sealable edges of the chamber 101.
  • the laminar air flow created minimises flow turbulence within the chamber 101 of the treatment apparatus 100, thereby preventing possible accumulation or trapping of pathogen-carrying droplets and/or aerosols at corners of the chamber 101.
  • the present embodiment with the exhaust opening 110 may also be fitted in rooms or facilities having integrated air suctions/pumps at, for example, the ceilings or walls of the rooms or facilities.
  • a velocity of the air flow is greater than 0.45 m/s.
  • the velocity of the air flow is in a range between 0.25 m/s to 0.32 m/s.
  • a pressure difference DR created between the confined space and the external environment is in the range of 0.3 to 0.8 Nrrr 2 .
  • the air filter is arranged between the fan 112 and the exhaust opening 110.
  • the air filter includes a High Efficiency Particulate Air (HEPA) filter which is capable of filtering sub-micron size particles including any infectious particles emitted by the patient.
  • HEPA High Efficiency Particulate Air
  • the air exhausted from the chamber 101 through the exhaust opening 110 via the air filter to the external environment is therefore treated/filtered before being discharged into the external environment.
  • the fan 112 comprises an air filter.
  • the air filter may be a separate component to the fan 112.
  • the exhaust opening 110 may be connected, via the air filter, to the fan 112.
  • the air filter may be connected to the outlet of the fan so that the fan 112 is operationally connected between the exhaust opening and the air filter.
  • the treatment apparatus 100 is also known as “DART” (Droplet and Aerosol Reducing Tent) and is useful in creating a confined space that contains the droplets and/or aerosol and limits environmental contamination.
  • the DART not only creates a physical barrier between the droplets and/or aerosol and the healthcare providers, but also allows the relatively the fine droplets in the air and/or aerosol within the confined space of the chamber 101 to be suctioned out prior to lifting of the chamber 101. Further, as explained above, the suction of air from the confined space through the exhaust opening 110 causes air to be drafted into the confined space from the external environment, thereby providing the patient with an oxygen-enhanced environment.
  • the top panel 108 and the wall panels 102, 104, 106 are made of polycarbonate.
  • the high material strength and light weight of polycarbonate makes the panels 102, 104, 106, 108 portable.
  • the surfaces of polycarbonate can also be transparent to aid visibility of the patient through the panels 102, 104, 106, 108, and can be easily disinfected.
  • the cost of polycarbonate is also relatively low so that these panels 102, 104, 106, 108 can be replaced or disposed if necessary. It should be appreciated that other materials for forming these panels 102, 104, 106, 108 are possible as long as these panels are disposable or amenable to standard methods of disinfection. Also it should be recognised that these panels should be light weight to allow for manoeuvrability and/or portability, and should be transparent to allow for visibility and access to the patient.
  • these panels 102, 104, 106, 108 are each connected to at least one adjacent panel.
  • the front panel 102 is connected to the side panels 104, 106 on opposite sides of the front panel 102, while the front panel 102 is connected to the top panel 108 on a third side between the two opposite sides.
  • the plurality of panels 102, 104, 106, 108 are connected to one another via at least one living hinge 114.
  • each living hinge is made of carbon reinforced nylon.
  • additional hinges 116 may be used to reinforce the strength of the living hinge or the connection between adjacent panels. It should be appreciated that in alternative embodiments, other form of hinges can be used as long as the panels are connected to one another in such a manner that they can be form the chamber 101 in the deployed state as shown in Figure 1.
  • Figure 2 shows the plurality of panels 102, 104, 106 and 108 of the treatment apparatus
  • the plurality of panels 102, 104, 106, 108 connected in the manner as described above allows the panels 102, 104, 106, 108 to be folded on top of one another in a flat-packed or storage state 200.
  • the plurality of panels 102, 104, 106, 108 can be unpacked and deployed to form the chamber
  • Figure 3 shows the treatment apparatus 100 of Figure 1 together with removable snap-in flanges 302a, 302b, 304a which can be fitted onto through holes of the plurality of panels according to an embodiment.
  • the removable snap-in flanges 302a, 302b, 304a are each provided to engage a perimeter of each of the through holes 102a, 102b, 104a for securing to each of the through holes 102a, 102b, 104a at least one of: a cover for the through hole and a user protection sleeve.
  • the snap-in-flanges 302a, 302b, 304a allow for customizability of arm port covering (sleeves or diaphragm).
  • the snap-in- flanges 302a, 302b, 304a also allow the cover or the user protection sleeve to be removable and to be replaced if necessary. This eases cleaning of these covers or protection sleeves, and alleviates concerns about their contamination. Further, the through holes and the removable snap-in flanges can also be customized to allow for different preferences, usability, and availability.
  • the snap-in flanges should be flexible enough to be fitted into the through holes with relative ease, and should be strong enough for regular cleaning or disinfection.
  • each snap-in flange is made of polyoxymethylene.
  • Figure 4 shows an integrated locking feature of the treatment apparatus 100 according to an embodiment.
  • the plurality of panels 102, 104, 106, 108 are unfolded to form the chamber 101 with the top panel 108 being connected to the side panels 104, 106 using a peg-in-hole type of locking feature 402.
  • Figure 4 is a blown-up schematic which is showing only one of these locking features 402 at one side of the top panel 108, although it should be appreciated that an equivalent locking feature 402 can be formed at an opposite side of the top panel 108 to secure the top panel 108 to the other side panel 104.
  • the peg-in-hole type of locking feature 402 includes a peg 404 attached to the side panel 106 and a complementary hole 406 which is fixedly connected to a side of a bottom surface of the top panel 108.
  • the peg 404 is fitted into the complementary hole 406 so that the top panel 108 is secured to the side panel 106.
  • other types of fitting joint/arrangement can be made as long as the top panel 108 can be removably secured to the side panels 104, 106 when the treatment apparatus 100 is deployed.
  • the top panel 108 is connected to a top edge of one of the wall panels 106 via at least one living hinge 114.
  • the top panel 108 can be flipped downwards so that the complementary holes 406 at the sides of the bottom surface of the top panel 108 can be engaged with the pegs 404 attached to the side panels 104, 106.
  • Figure 5 shows the fan unit 112 (or a vacuum pump) being connected to the exhaust opening 110 at the top panel 108 of the treatment apparatus of Figure 1 according to an embodiment.
  • the fan 112 comprises at least one ultra violet C (U V-C) light column (not shown) arranged within an air column of the fan 112 and is adapted to emit UV light to treat exhaust air within the air column.
  • U V-C ultra violet C
  • the UV light may have a wavelength between about 200 nm and 300 nm, which is strongly absorbed by nucleic acids for disinfection of infectious particles or microorganisms. It should be appreciated that the UV-C light column is an optional feature.
  • the fan 112 may be a portable fan (or a portable vacuum pump system) which can be deployed in an external setting (e.g. for field deployment). In this external setting, the fan 112 may allow at least 15 air exchanges per hour.
  • the fan 112 may be an indoor fan system (or an indoor vacuum pump system) that is suitable for an indoor setting (e.g. integrated fan system in a hospital or clinic). Similar frequency for air exchanges (i.e. 15 or more air exchanges per hour) can be used in the indoor setting. This frequency is advantageous for the present COVID-19 pandemic.
  • an additional through hole or opening 502 can be provided in the top panel 108. This through hole or opening 502 can provide additional access to the confined space of the chamber 101.
  • Figure 6 shows various dimensions of the treatment apparatus of Figure 1 according to an embodiment, where the dimensions as shown are measured in millimetres.
  • the dimensions of the treatment apparatus may be customised to suit the size of the patient (e.g. different sizes for children and adults).
  • a method of deploying the treatment apparatus 100 of Figure 1 comprises: assembling the plurality of panels 102, 104, 106, 108 to form the chamber 101; connecting the fan 112 to the exhaust opening 110; and using the fan 112 for generating the air flow from the confined space, via the air filter, to an external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • the treatment apparatus 100 when deployed, it can be placed in an area over the head of a patient and up to the shoulders of the patient. With the chamber 101 having three wall panels 102, 104, 106, the remaining body of the patient can be protruded out from the open side of the chamber 101.
  • the patient is therefore partially enclosed in the confined space of the chamber 101.
  • the covering can be used to lay over a portion of the remaining body of the patient on the open side of the chamber 101 (i.e. opposite side to the front panel 102), thereby creating a more confined environment within the chamber 101.
  • the plurality of panels 102, 104, 106, 108 may be stored in the flat-packed or storage state 200 as shown in Figure 2 initially.
  • the plurality of panels 102, 104, 106, 108 are unfolded from the flat-packed state 200.
  • Pegs 404 on each of the side panels 104, 106 are then fitted into the complementary holes 406 located at the sides of the top panel 108 (or located at a bottom surface at the sides of the top panel 108) to secure the side panels 104, 106 to the top panel 108 to assemble the plurality of panels 102, 104, 106, 108 to form the chamber 101.
  • a fan 112 adapted to connect to an air filter can then be connected to the exhaust opening 110 at the top panel 108.
  • the fan 112 can then be turned on to generate the air flow from the confined space, via the air filter, to the external environment for drafting air from the external environment into the confined space to ventilate the confined space.
  • the method of deploying the treatment apparatus 100 includes providing a number of snap-in flanges each provided to engage the perimeter of each of the through holes for securing to each of the through holes at least one of: a cover of the through hole and a user protection sleeve. This is an optional step and it should be appreciated that in some embodiments, snap-in flanges and/or covers or user protection sleeve may not be required.
  • the method comprises decontaminating interior surfaces of the chamber 101 before and after each use of the treatment apparatus 100.
  • the work surfaces and interior walls of the chamber 101 can be disinfected with any suitable means that will kill any infectious particles or microorganisms within the confined space of the chamber 101.
  • surface decontamination can include steam sterilization or a wipe-down of the work surfaces, the sides, back and interior of the panels.
  • a solution of HOCI / bleach or 70% alcohol which is effective against micro-organisms can be used.
  • a second wiping with sterile water is needed if a corrosive disinfectant, such as bleach, is used.
  • the sterilization process such as wipe down sequence, number of times of wipe down and/or concentrations of detergents used can be customized depending on the size of infectious particles on the surface of the panel.
  • the method comprises maintaining use of the fan 112 during a procedure or after the procedure on the patient is completed. This can be achieved by leaving the fan 112 to run for an extensive period of time or to use the fan 112 to provide a few rounds of air exchanges between the confined space in the chamber 101 and the external environment. This helps to ensure that the atmosphere inside the chamber 101 is purged to reduce the air bioburden before the fan 112 is switched off or removed.
  • the method comprises of covering the confined space of the chamber 101 using a covering (e.g. a drape or a hood) connected to the top panel 108 when the patient is partially enclosed therein.
  • a covering e.g. a drape or a hood
  • Alternative embodiments of the invention include: (i) placement and number of through holes provided in the panels can be configured depending on accessibility and needs (e.g. through holes provided in the top panel 108 or another side panel 106 of the chamber 101); (ii) the exhaust opening being provided near a bottom of a side panel for connection to a fan adapted to connect to an air filter; (iii) the air filter is a ULPA (Ultra Low Penetration Air) filter; (iv) a number of through holes are provided in the top panel and is adapted to provide accessibility to the confined space; (v) a covering (e.g.
  • the covering may be adapted to cover at least an opposite side of the chamber to the front panel for enclosing the confined space;
  • the plurality of panels 102, 104, 106, 108 are made of polyvinyl chloride (PVC) or acrylic;
  • two wall panels instead of the three wall panels shown in Figure 1) to form a chamber with a triangular footprint;
  • the panels 102, 104, 106, 108 are individual modules which are separated and only assembled together when deployed, e.g.
  • one or more ultra violet C (UV-C) light columns are arranged within the confined space and is adapted to emit UV light towards a surface of the panel to sterilize it, (x) the plurality of panels 102, 104, 106, 108 are assembled together to create gaps there between which provide accessibility to the confined space (e.g.
  • vapours within the confined space of the treatment chamber can sometimes be dense and can prevent infectious particles or micro-organisms from rising up.
  • the exhaust opening is provided at a range of 1.0 to 6.0 cm from a bottom end of the side panel.
  • the UCLA filter has a filtration rate of 99.999% at 0.12 microns.
  • ULPA filters effectively capture and filter surgical smoke to remove odour, particulates, and other potentially hazardous by products of electro-surgery procedures. Coupling this feature of low particle penetration with sterilisation of air e.g. with UV-C, this ensure that contaminated air from the confined space of the chamber 101 is effectively treated before being admitted to the external environment. This is particularly important for facilities which have no airlock and thereby allow air to be recirculated back by the AHU (air handling unit) for air conditioning.
  • AHU air handling unit
  • having the panels as individual modules improve the ease of replacing each of these panels. This also aids in the disposal of individual panel or the sterilization of each of these panels.
  • the UV-C light may have a wavelength between about 200 nm and 300 nm which are strongly absorbed by nucleic acids for disinfection of infectious particles or microorganisms. Infectious particles emitted from the patient would come into contact with the surfaces of the panels and there is a need for constant sterilization.
  • the UV-C is effective in removing infectious particles or micro organisms and thus keeping the patient safe within the confined space of the treatment chamber.
  • the combination of both filtration of at least at 0.3 urn and UV-C will provide an adequate level of safety for healthcare workers performing e.g. AGPs on a patient, particularly if the facility has 60% return air mixture.
  • a cap which can be fitted into the exhaust opening is provided.
  • the cap can be used to seal the exhaust opening.
  • the cap can be fitted to the exhaust opening to minimize air flowing from the confined space to the external environment.
  • an air flow generated by the vacuum pump may create a pressure difference between the external environment and the confined space.
  • a lower pressure is created in the confined space in relation to the external environment as air is being drawn from the confined space, via the air filter, to the external environment.
  • this relatively lower pressure creates a flow of air from the external environment to ventilate the chamber.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)

Abstract

La présente invention concerne un appareil de traitement. Dans un mode de réalisation, l'appareil de traitement comprend : une pluralité de panneaux assemblés pour former une chambre afin de fournir un espace confiné pour enfermer au moins partiellement un patient à l'intérieur de celle-ci; un ventilateur conçu pour être relié à un filtre à air; et une ouverture d'échappement disposée dans l'un de la pluralité de panneaux, l'ouverture d'échappement étant conçue pour être reliée au ventilateur, le ventilateur étant conçu pour générer un flux d'air à partir de l'espace confiné, par l'intermédiaire du filtre à air, vers un environnement externe pour aspirer de l'air de l'environnement externe dans l'espace confiné afin de ventiler l'espace confiné. L'invention concerne également un procédé de déploiement de l'appareil de traitement et un kit de pièces conçu pour être assemblé pour former l'appareil de traitement.
PCT/SG2021/050274 2020-05-20 2021-05-19 Appareil de traitement et procédé de déploiement d'un appareil de traitement Ceased WO2021236013A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202180044051.2A CN116033880A (zh) 2020-05-20 2021-05-19 治疗设备和部署治疗设备的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10202004719W 2020-05-20
SG10202004719W 2020-05-20

Publications (1)

Publication Number Publication Date
WO2021236013A1 true WO2021236013A1 (fr) 2021-11-25

Family

ID=78718221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2021/050274 Ceased WO2021236013A1 (fr) 2020-05-20 2021-05-19 Appareil de traitement et procédé de déploiement d'un appareil de traitement

Country Status (2)

Country Link
CN (1) CN116033880A (fr)
WO (1) WO2021236013A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220104982A1 (en) * 2020-10-01 2022-04-07 Mach32 Inc. Portable negative pressure isolation unit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728041A (en) * 1996-04-10 1998-03-17 Lone Star Medical Products, Inc. Isolator for use in surgery or as a clean room and method of using the same
US20080041399A1 (en) * 2004-03-24 2008-02-21 Hans Rudolf Kriek Sterile Enclosures
WO2018014003A1 (fr) * 2016-07-15 2018-01-18 Surgibox Inc. Système ultraportable pour l'isolation peropératoire et la régulation d'environnements de sites chirurgicaux
CN111437134A (zh) * 2020-05-02 2020-07-24 深圳市妇幼保健院 用于口腔操作治疗的防护隔离装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728041A (en) * 1996-04-10 1998-03-17 Lone Star Medical Products, Inc. Isolator for use in surgery or as a clean room and method of using the same
US20080041399A1 (en) * 2004-03-24 2008-02-21 Hans Rudolf Kriek Sterile Enclosures
WO2018014003A1 (fr) * 2016-07-15 2018-01-18 Surgibox Inc. Système ultraportable pour l'isolation peropératoire et la régulation d'environnements de sites chirurgicaux
CN111437134A (zh) * 2020-05-02 2020-07-24 深圳市妇幼保健院 用于口腔操作治疗的防护隔离装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220104982A1 (en) * 2020-10-01 2022-04-07 Mach32 Inc. Portable negative pressure isolation unit

Also Published As

Publication number Publication date
CN116033880A (zh) 2023-04-28

Similar Documents

Publication Publication Date Title
US5240478A (en) Self-contained, portable room air treatment apparatus and method therefore
US20040255937A1 (en) Personal isolation apparatus for preventing infection of SARS or the like
US5728041A (en) Isolator for use in surgery or as a clean room and method of using the same
JP5133939B2 (ja) 隔離室形成装置及び隔離室形成燻蒸方法
JP5475319B2 (ja) 隔離室形成装置、及び、隔離室清浄燻蒸方法
CN118647439A (zh) 包括改进的空气过滤单元的可移动空气过滤患者隔离系统、可移动空气过滤实验室隔离系统和可移动房间空气过滤系统
EP0619108A1 (fr) Appareil pour isoler un patient
EP1506023A2 (fr) Dispositifs de decontamination d'air
JP5475320B2 (ja) 隔離室形成装置及び隔離室形成方法
CN111195181B (zh) 一种新型冠状病毒防喷溅和减少病毒气溶胶扩散的装置
JP2005512744A5 (fr)
KR20040071244A (ko) 공기유동 격리장치
EP0357603A1 (fr) Tente d'isolation, de sterilisation et d'observation maximale
WO2021236013A1 (fr) Appareil de traitement et procédé de déploiement d'un appareil de traitement
JP2023548956A (ja) 隔離室システム及び方法
CN212973657U (zh) 一种帐篷式汽化过氧化氢灭菌消毒装置
US7934981B2 (en) Patient isolation module and use thereof
JPH07241318A (ja) 無菌ブース
CN111449855A (zh) 传染性疾患传染源的负压高效颗粒空气过滤净化隔离平台
JP5198311B2 (ja) 防護装備、隔離設備およびフィルタ
CA2556140C (fr) Module d'isolement de patient et son utilisation
CN217400470U (zh) 一种避免交叉感染的核酸采样方舱
JP5393250B2 (ja) 隔離室形成装置
JPH07198178A (ja) 空気清浄器
CN211863168U (zh) 一种新型冠状病毒防喷溅和减少病毒气溶胶扩散的装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21809792

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21809792

Country of ref document: EP

Kind code of ref document: A1

WWG Wipo information: grant in national office

Ref document number: 11202260085T

Country of ref document: SG